CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis (Q56898701)

From Wikidata

Jump to navigation Jump to search

scholarly article by Crisol Álvarez-Quiroga et al published August 2011 in Journal of Clinical Immunology

Language	Label	Description	Also known as
English	CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis	scholarly article by Crisol Álvarez-Quiroga et al published August 2011 in Journal of Clinical Immunology

Statements

scholarly article

0 references

CTLA-4-Ig therapy diminishes the frequency but enhances the function of Treg cells in patients with rheumatoid arthritis (English)

0 references

0 references

rheumatoid arthritis

1 reference

based on heuristic

inferred from title

author name string

Crisol Álvarez-Quiroga

1

0 references

Carlos Abud-Mendoza

2

0 references

Lesly Doníz-Padilla

3

0 references

Amida Juárez-Reyes

4

0 references

Adriana Monsiváis-Urenda

5

0 references

Lourdes Baranda

6

0 references

Roberto González-Amaro

7

0 references

language of work or name

0 references

publication date

August 2011

0 references

Journal of Clinical Immunology

0 references

31

0 references

4

0 references

588-95

0 references

https://scigraph.springernature.com/pub.10.1007/s10875-011-9527-5

0 references

CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

T-cell regulation by CD28 and CTLA-4.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Mechanisms of costimulation

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Revisiting the role of IL-2 in autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Specific subsets of murine dendritic cells acquire potent T cell regulatory functions following CTLA4-mediated induction of indoleamine 2,3 dioxygenase

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

TGF-beta: the missing link in CD4+CD25+ regulatory T cell-mediated immunosuppression

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

TGF-beta enhances effector Th1 cell activation but promotes self-regulation via IL-10.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CTLA-4 can function as a negative regulator of T cell activation

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Bench to bedside of CTLA-4: a novel immuno-therapeutic agent for inflammatory disorders

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Sequential use of biologic therapy in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

[Selective co-stimulation blockade. CTLA4-Ig (Abatacept)].

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Generation and regulation of CD8(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Regulatory T cells in patients with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Disturbed regulatory T cell homeostasis in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CTLA4Ig gene transfer alleviates abortion in mice by expanding CD4+CD25+ regulatory T cells and inducing indoleamine 2,3-dioxygenase

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Absence of CD4CD25 regulatory T cell expansion in renal transplanted patients treated in vivo with Belatacept mediated CD28-CD80/86 blockade

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

CD2 costimulation reveals defective activity by human CD4+CD25(hi) regulatory cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

A role for the transcription factor Helios in human CD4(+)CD25(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS10875-011-9527-5

21 January 2018

Modulation of CTLA-4 and GITR for cancer immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21487894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21487894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21487894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ANTI-CD3 therapy expands the numbers of CD4+ and CD8+ Treg cells and induces sustained amelioration of collagen-induced arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21487894

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-011-9527-5

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q56898701&oldid=1546238808"